Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?
Cardiovascular diseasesdrug prescriptionsgeneral practiceold agesecondary preventionthe Netherlandsvulnerability
